Bioxtreme secures Serra Holding-led strategic investment as total funding reaches USD 15 million
Evidence notes
- Bioxtreme announced a strategic investment led by Serra Holding.
- The company said the investment brings total funding to USD 15 million to date.
- The financing supports global expansion, stronger operations in the United States and Europe, and continued neurorehabilitation robotics development.
Company context
Bioxtreme develops robotic rehabilitation systems for upper-limb and hand recovery in patients with neurological injuries including stroke and traumatic brain injury. Its systems use precision robotics, immersive therapy tasks, real-time movement sensing, and proprietary error augmentation forces to support motor relearning.